Beijing Tong Ren Tang Chinese Medicine Company Limited (3613.HK)
HKD 8.42
(0.0%)
HKD 8.42
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 460.83 Million | 547.44 Million | 777.17 Million | 116.05 Million | 551.01 Million | 577.68 Million |
| Net Income | 540.39 Million | 825.96 Million | 778.39 Million | 685.89 Million | 689.22 Million | 720.89 Million |
| Depreciation & Amortization | 82.51 Million | 75.47 Million | 69.97 Million | 78.08 Million | 79.24 Million | 30.84 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -34.32 Million | -326.91 Million | 60.04 Million | -421.95 Million | -185.87 Million | -22.34 Million |
| Other non-cash items | 2.95 Million | -27.07 Million | -131.23 Million | -225.97 Million | -31.58 Million | -151.71 Million |
| Investing Cash Flow | -1.07 Billion | 335.41 Million | -265.73 Million | 506.72 Million | 835.54 Million | -597.93 Million |
| Investments in PPE | -21.86 Million | -38.5 Million | -23.42 Million | -12.88 Million | -16.99 Million | -53.22 Million |
| Acquisitions | 56 Thousand | -3.25 Million | -53.38 Million | 30 Thousand | 108 Thousand | 2.72 Million |
| Investment purchases | -1.12 Billion | -362.26 Million | -233.99 Million | -30 Thousand | -804.06 Million | -568.27 Million |
| Sales/Maturities of investments | - | 362.26 Million | 233.99 Million | 490.55 Million | 803.95 Million | - |
| Other Investing Activities | -1.05 Billion | 377.18 Million | -188.92 Million | 29.05 Million | 852.53 Million | 23.56 Million |
| Financing Cash Flow | -372.18 Million | -535.41 Million | -278.64 Million | -264.29 Million | -878.66 Million | -173 Million |
| Debt repayment | -220 Thousand | -433 Thousand | -166 Thousand | -166 Thousand | -166 Thousand | -522 Thousand |
| Dividends payments | -276.24 Million | -443.66 Million | -200.9 Million | -192.54 Million | -795.23 Million | -159.04 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -37.2 Million | -91.32 Million | -77.57 Million | -71.59 Million | -83.26 Million | -13.43 Million |
| Accounts receivables | 492.15 Million | -434.15 Million | 23.18 Million | -219.54 Million | -133.9 Million | -20.84 Million |
| Accounts payables | 17.12 Million | 154.24 Million | -28.1 Million | -33.66 Million | 30.31 Million | 15.24 Million |
| Inventory | -543.59 Million | -46.99 Million | 64.95 Million | -168.75 Million | -82.28 Million | -16.75 Million |
| Other working capital | 17.12 Million | - | - | - | -1.00 | -5.59 Million |
| Cash at beginning of period | 1.99 Billion | 1.66 Billion | 1.42 Billion | 1.05 Billion | 549.83 Million | 750.44 Million |
| Cash at end of period | 999.81 Million | 1.99 Billion | 1.66 Billion | 1.42 Billion | 1.05 Billion | 549.83 Million |
| Capital Expenditure | -21.86 Million | -38.5 Million | -23.42 Million | -12.88 Million | -16.99 Million | -53.22 Million |
| Effect of forex changes on cash | -1.28 Million | -16.77 Million | 1.47 Million | 10.84 Million | -1 Million | -7.35 Million |
| Net cash flow / Change in cash | -991.15 Million | 330.66 Million | 234.26 Million | 369.32 Million | 506.88 Million | -200.61 Million |
| Free Cash Flow | 438.96 Million | 508.93 Million | 753.74 Million | 103.17 Million | 534.02 Million | 524.45 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 109.89 Million | 109.89 Million | 540.39 Million | 137.17 Million | 137.17 Million | 133.02 Million |
| Depreciation & Amortization | 21.45 Million | 21.45 Million | 82.51 Million | 21.15 Million | 20.63 Million | 19.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | -34.32 Million | -25.72 Million | -25.72 Million | - |
| Other non-cash items | -283.27 Million | -283.27 Million | 2.95 Million | -159.46 Million | -158.95 Million | 104.66 Million |
| Investing Cash Flow | 675.21 Million | 675.21 Million | -1.07 Billion | -363.73 Million | -363.73 Million | -175.52 Million |
| Investments in PPE | -5.6 Million | -5.6 Million | -21.86 Million | -7.42 Million | -7.42 Million | -3.51 Million |
| Acquisitions | - | - | 56 Thousand | 25 Thousand | - | 31 Thousand |
| Investment purchases | - | - | -1.12 Billion | -757.54 Million | - | -368.33 Million |
| Sales/Maturities of investments | - | - | - | - | - | 172 Million |
| Other Investing Activities | 680.82 Million | 680.82 Million | -1.05 Billion | -356.31 Million | -356.31 Million | -172 Million |
| Financing Cash Flow | -160.11 Million | -160.11 Million | -372.18 Million | -24.59 Million | -24.59 Million | -161.49 Million |
| Debt repayment | - | - | -220 Thousand | -84 Thousand | - | -136 Thousand |
| Dividends payments | -138.12 Million | -138.12 Million | -276.24 Million | - | - | -138.12 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -21.99 Million | -21.99 Million | -37.2 Million | -24.59 Million | -24.59 Million | -23.37 Million |
| Accounts receivables | - | - | 492.15 Million | 246.07 Million | 246.07 Million | - |
| Accounts payables | - | - | 17.12 Million | - | - | - |
| Inventory | - | - | -543.59 Million | -271.79 Million | -271.79 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | - | - | 1.99 Billion | 2.44 Billion | - | 1.99 Billion |
| Cash at end of period | 360.83 Million | 360.83 Million | 999.81 Million | 999.81 Million | -413.49 Million | 2.44 Billion |
| Capital Expenditure | -5.6 Million | -5.6 Million | -21.86 Million | -7.42 Million | -7.42 Million | -3.51 Million |
| Effect of forex changes on cash | -2.33 Million | -2.33 Million | -1.28 Million | 1.68 Million | 1.68 Million | -2.33 Million |
| Net cash flow / Change in cash | 360.83 Million | 360.83 Million | -991.15 Million | -1.44 Billion | -413.49 Million | 457.17 Million |
| Free Cash Flow | -157.53 Million | -157.53 Million | 438.96 Million | -34.27 Million | -34.27 Million | 253.75 Million |
L&E
INCON
BGTTF
CAPRIHANS
600604
NYMTZ